Adamas Pharmaceuticals Inc (ADMS) - Financial and Strategic SWOT Analysis Review

  • ID: 4285284
  • SWOT Analysis
  • 42 pages
  • GlobalData
1 of 5
Adamas Pharmaceuticals Inc (ADMS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief Summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Adamas Pharmaceuticals Inc (Adamas) is a pharmaceutical company that develops and commercializes therapeutics for chronic disorders of the central nervous system. The company's pipeline products include ADS-5102, which is used for the treatment of CNS-related conditions including levodopa-induced dyskinesia in Parkinson's disease patients; and major symptoms associated with multiple sclerosis in patients with walking impairment. Adamas’ product portfolio also includes namzaric and namenda XR. Its products are also used in the treatment of traumatic brain injury. The company serves in different parts of the US. Adamas is headquartered in Emeryville, California, the US.

Adamas Pharmaceuticals Inc Key Recent Developments

Jun 28,2017: Adamas Appoints New Chief Financial Officer
May 09,2017: Adamas Reports Recent Achievements and First Quarter 2017 Financial Results
Feb 28,2017: Adamas Reports Recent Achievements and Financial Results for the Fourth Quarter and Full-Year 2016
Nov 03,2016: Adamas Reports Third Quarter 2016 Financial Results
Sep 22,2016: Adamas Appoints Michael F. Bigham to Board of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5
Section 1 - About the Company
Adamas Pharmaceuticals Inc - Key Facts
Adamas Pharmaceuticals Inc - Key Employees
Adamas Pharmaceuticals Inc - Major Products and Services
Adamas Pharmaceuticals Inc - History
Adamas Pharmaceuticals Inc - Company Statement
Adamas Pharmaceuticals Inc - Locations And Subsidiaries
Head Office

Section 2 - Company Analysis
Adamas Pharmaceuticals Inc - Business Description
Adamas Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Adamas Pharmaceuticals Inc - Strengths
Adamas Pharmaceuticals Inc - Weaknesses
Adamas Pharmaceuticals Inc - Opportunities
Adamas Pharmaceuticals Inc - Threats
Adamas Pharmaceuticals Inc - Key Competitors

Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances
Adamas Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Adamas Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Adamas Pharmaceuticals Inc, Recent Deals Summary

Section 5 - Company’s Recent Developments
Jun 28, 2017: Adamas Appoints New Chief Financial Officer
May 09, 2017: Adamas Reports Recent Achievements and First Quarter 2017 Financial Results
Feb 28, 2017: Adamas Reports Recent Achievements and Financial Results for the Fourth Quarter and Full-Year 2016
Nov 03, 2016: Adamas Reports Third Quarter 2016 Financial Results
Sep 22, 2016: Adamas Appoints Michael F. Bigham to Board of Directors
Aug 04, 2016: Adamas Reports Second Quarter 2016 Financial Results
May 10, 2016: Adamas Reports First Quarter 2016 Financial Results
Feb 23, 2016: Adamas Reports Fourth Quarter and Full Year 2015 Financial Results
Jan 12, 2016: Adamas Pharmaceuticals Provides Review of 2015 and Projected Future Milestones

Section 6 - Appendix
Methodology
Ratio Definitions
About
Contact
Disclaimer

List of Tables
Adamas Pharmaceuticals Inc, Key Facts
Adamas Pharmaceuticals Inc, Key Employees
Adamas Pharmaceuticals Inc, Major Products and Services
Adamas Pharmaceuticals Inc, History
Adamas Pharmaceuticals Inc, Key Competitors
Adamas Pharmaceuticals Inc, Ratios based on current share price
Adamas Pharmaceuticals Inc, Annual Ratios
Adamas Pharmaceuticals Inc, Annual Ratios (Cont...1)
Adamas Pharmaceuticals Inc, Annual Ratios (Cont...2)
Adamas Pharmaceuticals Inc, Interim Ratios
Adamas Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Adamas Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Adamas Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Adamas Pharmaceuticals Inc, Performance Chart (2012 - 2016)
Adamas Pharmaceuticals Inc, Ratio Charts
Adamas Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Adamas Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Zogenix Inc
  • Depomed Inc
  • AcelRx Pharmaceuticals Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll